BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7515025)

  • 41. Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulated.
    Patel DD; Hale LP; Whichard LP; Radcliff G; Mackay CR; Haynes BF
    Int Immunol; 1995 Feb; 7(2):277-86. PubMed ID: 7537537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of CD44 in prostate cancer cells.
    Liu AY
    Cancer Lett; 1994 Jan; 76(1):63-9. PubMed ID: 7510214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential.
    Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ
    Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44 variant expression in cutaneous T-cell lymphoma.
    Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ
    J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
    Finke LH; Terpe HJ; Zörb C; Haensch W; Schlag PM
    Lancet; 1995 Mar; 345(8949):583. PubMed ID: 7539876
    [No Abstract]   [Full Text] [Related]  

  • 50. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
    van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
    Dougherty GJ; Landorp PM; Cooper DL; Humphries RK
    J Exp Med; 1991 Jul; 174(1):1-5. PubMed ID: 2056274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
    Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
    Hofmann M; Rudy W; Zöller M; Tölg C; Ponta H; Herrlich P; Günthert U
    Cancer Res; 1991 Oct; 51(19):5292-7. PubMed ID: 1717145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines.
    Bloor BK; Jelvagharan M; White KN; Odell EW
    Int J Oncol; 2001 May; 18(5):1053-9. PubMed ID: 11295056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J; Schirrmacher V; Mosier D
    Int J Cancer; 1995 May; 61(3):363-9. PubMed ID: 7537255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.
    Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR
    Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD44 isoforms during differentiation and development.
    Ruiz P; Schwärzler C; Günthert U
    Bioessays; 1995 Jan; 17(1):17-24. PubMed ID: 7535522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.